TCL Archive Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival October 29, 2010
TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive Also in this 8-page issue: Senate Labor-HHS finds an extra $1 billion for NIH; Appropriations Committee reports bill to Senate. July 15, 2005
TCL Archive Promotions at MSKCC: Fuks heads radiation oncology, Pfister named chief of Head & Neck Medical Oncology Service. October 15, 2004
